Targeting MTHFD2 to exploit cancer-specific metabolism and the DNA damage response

Ramos, L. orcid.org/0000-0002-3808-6853, Henriksson, M. orcid.org/0000-0002-2230-4887, Helleday, T. orcid.org/0000-0002-7384-092X et al. (1 more author) (2023) Targeting MTHFD2 to exploit cancer-specific metabolism and the DNA damage response. Cancer Research. ISSN 0008-5472

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2023 The Authors. Except as otherwise noted, this author-accepted version of a journal article published in Cancer Research is made available via the University of Sheffield Research Publications and Copyright Policy under the terms of the Creative Commons Attribution 4.0 International License (CC-BY 4.0), which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/
Keywords: Cancer; Pharmaceuticals; Development of treatments and therapeutic interventions; Cancer
Dates:
  • Submitted: 8 May 2023
  • Accepted: 31 October 2023
  • Published (online): 3 November 2023
  • Published: 3 November 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > The Medical School (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology and Metabolism (Sheffield)
The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 23 Nov 2023 16:07
Last Modified: 23 Nov 2023 16:07
Status: Published online
Publisher: American Association for Cancer Research (AACR)
Refereed: Yes
Identification Number: https://doi.org/10.1158/0008-5472.can-23-1290
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)